2m 2m 2m 2m 2m 2m 2m
Kamada Ltd Br (KMDA)
NASDAQ
$7.39-$0.12 (-1.60%)
Price as of Jun 03, 2026 4:10 PM EDT- $284.4MMarket Cap
- 14.97%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Kamada Ltd Br (KMDA)
$7.39-$0.12 (-1.60%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 156.2M -2.95% | 161.0M +12.93% | 142.5M +10.19% | 129.3M +24.79% | |
Cost of Revenue | 83.9M -7.76% | 91.0M +4.55% | 87.0M +5.32% | 82.6M +12.72% | |
Gross Profit | 76.4M +9.20% | 70.0M +26.09% | 55.5M +18.81% | 46.7M +53.99% | |
Sales and Marketing Expense | 18.5M +0.15% | 18.4M +13.80% | 16.2M +5.95% | 15.3M +143.45% | |
Research and Development Expense | -13.0M -14.42% | -15.2M +8.99% | -13.9M +5.78% | -13.2M +15.98% | |
Depreciation and Amortization Expense | 14.9M +8.04% | 13.8M +8.60% | 12.7M +136.50% | 5.4M -4.15% | |
Total Operating Expenses | 18.7M +19.25% | 15.7M +9.19% | 14.4M +12.33% | 12.8M +1.32% | |
Operating Profit | 26.2M +30.83% | 20.1M +99.23% | 10.1M +122.07% | 4.5M +751.15% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Total Nonoperating Income and Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Income before Taxes | 20.2M +39.66% | 14.5M +74.58% | 8.3M +456.92% | -2.3M +4.08% | |
Income Taxes | 3.3M +389.80% | -1.1M -877.93% | 145,000 +133.87% | 62,000 -82.03% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 20.2M +39.66% | 14.5M +74.58% | 8.3M +456.92% | -2.3M +4.08% | |
Net Income from Continuing Operations Applicable to Common | 20.2M +39.66% | 14.5M +74.58% | 8.3M +456.92% | -2.3M +4.08% | |
Basic EPS and Net Income | 0.35 +40.00% | 0.25 +47.06% | 0.17 +440.00% | -0.05 0.00% | |
Diluted EPS and Net Income | 0.35 +40.00% | 0.25 +66.67% | 0.15 +400.00% | -0.05 0.00% | |
Basic Weighted Average Shares | 57.6M +0.28% | 57.5M +17.73% | 48.8M +8.96% | 44.8M +0.10% | |
Diluted Weighted Average Shares | 57.6M +0.28% | 57.5M +17.73% | 48.8M +8.96% | 44.8M +0.10% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 75.5M -3.78% | 78.4M +40.97% | 55.6M +62.42% | 34.3M +84.31% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 75.5M -3.78% | 78.4M +40.97% | 55.6M +62.42% | 34.3M +84.31% | |
Total Current Assets | 193.1M +4.73% | 184.3M +8.46% | 170.0M +22.27% | 139.0M +6.89% | |
Accumulated Depreciation | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | 41.4M +14.13% | 36.2M +28.42% | 28.2M +7.90% | 26.2M -0.57% | |
Total Long-Term Assets | 185.6M -1.21% | 187.9M +1.60% | 184.9M +0.86% | 183.4M -2.78% | |
Total Assets | 378.7M +1.73% | 372.3M +4.89% | 354.9M +10.09% | 322.4M +1.16% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 47.4M -4.04% | 49.4M -0.41% | 49.6M -34.49% | 75.7M +40.05% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | 20.0M 0.00% | |
Total Long-Term Liabilities | 62.2M -1.82% | 63.4M +3.44% | 61.3M -13.25% | 70.7M -19.52% | |
Total Liabilities | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Retained Earnings | -17.1M -33.66% | -25.7M -35.98% | -40.2M -17.09% | -48.5M +5.03% | |
Total Stockholders Equity | 269.1M +3.70% | 259.5M +6.33% | 244.0M +38.63% | 176.0M -0.45% | |
Total Shares Outstanding | 57.7M +0.31% | 57.5M +0.04% | 57.5M +28.21% | 44.8M +0.07% | |
Cash Flow | |||||
Cash from Operating Activities | 25.5M -46.44% | 47.6M +1,002.99% | 4.3M -84.91% | 28.6M +424.14% | |
Capital Expenditures | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | -9.8M -8.39% | -10.7M +83.79% | -5.8M +54.41% | -3.8M -93.80% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -18.3M +31.87% | -13.9M -161.34% | 22.7M +342.73% | -9.3M -150.25% | |
Financials Ratio | |||||
Gross Margin | 46.27% +6.44% | 43.47% +11.65% | 38.94% +7.83% | 36.11% +23.40% | |
Operating Margin | 16.79% +34.81% | 12.46% +76.42% | 7.06% +101.53% | 3.50% +621.82% | |
Return on Assets | 5.38% +35.23% | 3.98% +62.61% | 2.45% +437.83% | -0.72% -14.06% | |
Return on Equity | 7.64% +33.04% | 5.74% +45.64% | 3.94% +399.82% | -1.32% +4.85% | |
Revenue Growth | -2.95% -122.80% | 12.93% +26.93% | 10.19% -58.90% | 24.79% +211.60% | |
Current Ratio | 4.07 +9.14% | 3.73 +8.91% | 3.43 +86.65% | 1.84 -23.68% | |
Cash Ratio | 1.59 +0.27% | 1.59 +41.54% | 1.12 +147.96% | 0.45 +31.62% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow